These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25532741)

  • 1. Determination of in vitro synergy for dual antimicrobial therapy against resistant Neisseria gonorrhoeae using Etest and agar dilution.
    Wind CM; de Vries HJ; van Dam AP
    Int J Antimicrob Agents; 2015 Mar; 45(3):305-8. PubMed ID: 25532741
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Li X; Le W; Lou X; Wang B; Genco CA; Rice PA; Su X
    Microbiol Spectr; 2021 Oct; 9(2):e0018121. PubMed ID: 34668731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era.
    Singh V; Bala M; Bhargava A; Kakran M; Bhatnagar R
    PLoS One; 2018; 13(3):e0193678. PubMed ID: 29509792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Synergy Testing of Gentamicin, an Old Drug Suggested as Future Treatment Option for Gonorrhoea, in Combination With Six Other Antimicrobials Against Multidrug-Resistant Neisseria gonorrhoeae Strains.
    Singh V; Bala M; Bhargava A; Kakran M; Bhatnagar R
    Sex Transm Dis; 2018 Feb; 45(2):127-131. PubMed ID: 28876284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae.
    Barbee LA; Soge OO; Holmes KK; Golden MR
    J Antimicrob Chemother; 2014 Jun; 69(6):1572-8. PubMed ID: 24468865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy for gonorrhoea: in vitro synergy testing.
    Pereira R; Cole MJ; Ison CA
    J Antimicrob Chemother; 2013 Mar; 68(3):640-3. PubMed ID: 23152483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of tigecycline alone and antimicrobial combinations against clinical Neisseria gonorrhoeae isolates.
    Lee H; Kim H; Seo YH; Yong D; Jeong SH; Lee K; Chong Y
    Diagn Microbiol Infect Dis; 2017 Feb; 87(2):160-162. PubMed ID: 27890419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro potency and combination testing of antimicrobial agents against Neisseria gonorrhoeae.
    Bharat A; Martin I; Zhanel GG; Mulvey MR
    J Infect Chemother; 2016 Mar; 22(3):194-7. PubMed ID: 26603424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates.
    Hauser C; Hirzberger L; Unemo M; Furrer H; Endimiani A
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1605-11. PubMed ID: 25547354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
    Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
    J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018.
    Boiko I; Golparian D; Krynytska I; Bezkorovaina H; Frankenberg A; Onuchyna M; Jacobsson S; Unemo M
    APMIS; 2019 Jul; 127(7):503-509. PubMed ID: 30903707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of antimicrobial combinations against clinical isolates of Neisseria gonorrhoeae.
    Furuya R; Koga Y; Irie S; Ikeda F; Kanayama A; Kobayashi I; Tanaka M
    J Infect Chemother; 2013 Dec; 19(6):1218-20. PubMed ID: 23564350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of agar dilution with the Calibrated Dichotomous Sensitivity (CDS) and Etest methods for determining the minimum inhibitory concentration of ceftriaxone against Neisseria gonorrhoeae.
    Enriquez RP; Goire N; Kundu R; Gatus BJ; Lahra MM
    Diagn Microbiol Infect Dis; 2016 Sep; 86(1):40-3. PubMed ID: 27342784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
    Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M;
    BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy and reproducibility of the Etest to detect drug-resistant Neisseria gonorrhoeae to contemporary treatment.
    Papp JR; Rowlinson MC; O'Connor NP; Wholehan J; Razeq JH; Glennen A; Ware D; Iwen PC; Lee LV; Hagan C
    J Med Microbiol; 2018 Jan; 67(1):68-73. PubMed ID: 29219803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro assessment of gentamicin and azithromycin-based combination therapy against Neisseria gonorrhoeae isolates in India.
    Sood S; Agarwal SK; Singh R; Gupta S; Sharma VK
    J Med Microbiol; 2019 Apr; 68(4):555-559. PubMed ID: 30869583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global resistance of Neisseria gonorrhoeae: when theory becomes reality.
    Lewis DA
    Curr Opin Infect Dis; 2014 Feb; 27(1):62-7. PubMed ID: 24275696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Susceptibility of Neisseria gonorrhoeae in Japan from 2000 to 2015.
    Yasuda M; Hatazaki K; Ito S; Kitanohara M; Yoh M; Kojima M; Narita H; Kido A; Miyata K; Deguch T
    Sex Transm Dis; 2017 Mar; 44(3):149-153. PubMed ID: 28178112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of the novel bicyclolides modithromycin (EDP-420, EP-013420, S-013420) and EDP-322 against MDR clinical Neisseria gonorrhoeae isolates and international reference strains.
    Jacobsson S; Golparian D; Phan LT; Ohnishi M; Fredlund H; Or YS; Unemo M
    J Antimicrob Chemother; 2015 Jan; 70(1):173-7. PubMed ID: 25182063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.